38.3 F
New Haven
Wednesday, November 18, 2026
- Advertisement -spot_img

Connecticut Leads 43-Plaintiff Coalition In Securing $400M Settlement From Drug Provider

Avatar photo

by Kate Santini

HARTFORD, CT — Sandoz, Inc. has  agreed in principle  to a $400 million settlement with 43 states and territories over their alleged monopolistic practices and inflated prices in the affordable drug market, according to Attorney General William Tong.

“Sandoz Inc. rigged the generic drug market, forcing customers to pay higher prices for critical medication. The company then fraudulently shielded its assets to evade accountability,” said Tong. “This settlement in principle ensures the company takes responsibility for its brazen actions and is a major step as we head to our first trial.” 

Sandoz, Inc. is a U.S. subsidiary of Swiss generic drug provider Sandoz Group AG. Founded in 1886, the group is now the largest generic and biosimilar provider on the globe, serving roughly 500 million patients daily. 

This is not the first time the company has faced legal scrutiny, Tong said. Its former parent company, Novartis, previously resolved a legal dispute with the US Department of Justice (DOJ) over overcharging customers and market manipulation for $195 million. Sandoz, Inc. also paid $265million  in a 2024 settlement with the state of Pennsylvania.

The company will now be paying a total of $478.5 million, with the extra $78.5 million going toward previous settlers and private resellers. The coalition of states will also be receiving $96.5 million worth of settlement funds from various pharmaceutical companies including Glenmark, Lannett, Bausch, Apotex, and Heritage.

Documents included text and email chains, recorded phone calls, and personal notebooks detailing tactics the company used to minimize competition, Tong said. 

While Sandoz, Inc. did not admit to wrongdoing, it issued a statement announcing its commitment to paying the fee over the course of a seven-year period in order to clear its name of any federal and state allegations. The statement also specified that the settlement is still awaiting approval from all parties involved and that these payments will not go into effect until 2027.

“These settlements underscore the company’s commitment to integrity, sound governance and resolving allegations of legacy conduct,” said the statement. As for any remaining claims, “Sandoz will continue to assess the overall situation and may increase or decrease the previously taken provision as appropriate.”


Discover more from InnerCity News

Subscribe to get the latest posts sent to your email.

Latest

National

Related news

Discover more from InnerCity News

Subscribe now to keep reading and get access to the full archive.

Continue reading